Urgent in the World

Breaking news, corroborated before it is published
← All stories
DEVELOPING — SINGLE SOURCE, NOT YET CORROBORATED

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

20 Oct 2026, 12:50 UTC · 1 source
Share: WhatsApp X Email

🚨 NOVO’S NEXT-GENERATION OBESITY DRUG SHOWS STRONGER WEIGHT-LOSS RESULTS Novo released new evidence that its experimental CagriSema injection can improve upon weight loss with Wegovy. In a late-stage analysis, it showed 25% weight loss in women. Source: CNBC #Novo #obesitydrug #women #latestageanalysis

Sources